Global and Refugee Health Research

Counterfeit and Substandard Pharmaceutical Testing

We are developing devices, methodologies and protocols to test for counterfeit and substandard pharmaceuticals that lead to mortality, morbidity and long-term drug resistance. We are working with governments, regulatory agencies and private entities to develop and implement newer technologies and better solutions to address the global challenge of counterfeit and substandard drugs.

For more information, please see our recent publications.

Antimicrobial Resistance

Poor quality medicines are a global health risk. We seek to address gaps in both experimental and social research involving the role of poor quality medicines in antibiotic resistance development. We are also developing integrated one-health approaches bringing human, veterinary and environmental health approaches to study the drivers and impact of antimicrobial resistance on communities at risk in both urban and rural areas in low and middle income countries.

For more information, please see our recent publications.


Improving access to healthcare in forcibly displaced communities

Using a suite of computational and experimental methods, and working with partners on the ground, we are studying barriers to accessing healthcare among forcibly displaced communities. These include refugees, internally displaced persons and stateless communities affected by conflict, persecution and climate change. We are developing ethically grounded, context-appropriate approaches (methodologies, programs, technologies and policies) to improve health outcomes among these forcibly displaced communities.

For more information, please see our recent publications.